Genomics News

• How Racist Is Your Algorithm? Researchers and health systems are reconsidering the use of race in tools that support clinical decision-making and are trying to raise awareness of racial bias.
  Medscape Medical News, July 01, 2022
• Can a Genetic Test Help Detect Early Kidney Disease? A newly developed of a polygenic risk score for kidney disease may lead to earlier detection and could also help trigger adoption of a protective lifestyle.
  Medscape Medical News, July 01, 2022
• Early Post-Stroke Gene Expression May Predict Stroke Outcomes Genes and associated networks regulating immune response may modulate 90-day ischemic stroke outcomes and be used to predict outcomes.
  First Look, June 30, 2022
• Genetic 'Taste Score' Could Help Us Eat Well, Reduce Disease Risk Tufts University researchers say new findings could advance personalized nutrition, improving diet and reducing the risk for obesity, diabetes, and heart disease.
  WebMD Health News, June 30, 2022
• EAN 2022 Specific Genetic Mutations Predict Parkinson's Disease Survival The type of genetic mutations patients with Parkinson's disease carry can affect survival time, new research suggests. Experts add the data will be useful for future drug development trials.
  Medscape Medical News, June 30, 2022
• AHS 2022 Twin Study Offers New Insight Into Genetics of Migraine Women with male twins are more likely to experience migraine without aura than those with female twins, even though testosterone is thought to be protective, new research suggests.
  Medscape Medical News, June 28, 2022
• First-Ever Huntington Staging System May Spur Drug Development The first-ever staging system for Huntington disease is a key step toward developing drugs that target the disorder before the onset of debilitating symptoms.
  Medscape Medical News, June 28, 2022
• Sleep a Potential Treatment Target for Schizophrenia? A new analysis reveals a bidirectional relationship between sleep patterns and schizophrenia, leading researchers to suggest sleep may be a potential treatment target for the disorder.
  Medscape Medical News, June 27, 2022
• Stroke Study Reveals a High Frequency of Mendelian Disorders A retrospective study demonstrated that exome sequencing is useful in evaluating stroke patients
  First Look, June 23, 2022
• Debated: Nonfactor Versus Gene Therapy for Hemophilia The question debated was, should patients with hemophilia A stick with effective nonfactor therapy or join a clinical trial for a potential cure with gene therapy?
  Medscape Medical News, June 23, 2022
• Broccoli Reigns Supreme As America's Favorite Veggie Broccoli takes home the win in Green Giant's annual survey.
  WebMD Health News, June 21, 2022
• Precision Medicine vs Antibiotic Resistance Therapeutic drug monitoring and genomics studies are among the tools that can help elucidate and circumvent bacteria's ability to resist antibiotics.
  Medscape Medical News, June 17, 2022
• Alert FDA Approves Setmelanotide for Obesity in Bardet-Biedl Syndrome The FDA cleared setmelanotide (Imcivree) for people age 6 and older with obesity due to a rare genetic disorder, Bardet-Biedl Syndrome, adding to its approval for other rare diseases causing obesity.
  FDA Approvals, June 17, 2022
• Disappointing Results for Investigational Alzheimer's Drug Crenezumab, an investigational medication designed to slow or prevent Alzheimer's disease, provides no cognitive benefit in patients at high genetic risk, new research suggests.
  Medscape Medical News, June 16, 2022
• EHA 2022 New Therapy May Offer 'Functional Cure' for Two Blood Disorders One infusion of an investigational gene editing therapy could eliminate red blood cell transfusions in beta-thalassemia and severe vaso-occlusive crises in sickle cell disease.
  Medscape Medical News, June 14, 2022
• Alert FDA Committee Unanimous on Two Gene Therapies An FDA advisory committee gave a unanimous thumbs up to two new gene therapies, one for beta-thalassemia and the other for a rare but fatal neurologic disorder.
  News Alerts, June 13, 2022
• Rare APOE Variants Reduce Alzheimer's Risk by More Than 60% Two rare missense mutations in APOE ε3 and ε4 isoforms reduce the risk of Alzheimer's disease by 50% or more and may serve as novel drug targets.
  Medscape Medical News, June 10, 2022
• 'Genetic' Height Linked to Peripheral Neuropathy, Other Disorders 'Genetic' height, the height a person is predicted to reach independent of environmental influences, may be an underappreciated risk factor for a wide range of chronic conditions, new research suggests.
  Medscape Medical News, June 09, 2022
• EPA 2022 Genetic Testing for Best Antidepressant Accurate, Cost-Effective Genetic testing to determine the best antidepressant for patients with major depression and has the potential to lead to an optimal drug choice on the first try and reduce healthcare costs, new research suggests.
  Medscape Medical News, June 09, 2022
• Celiac Disease and IBD Show Strong Bidirectional Link After the first year postdiagnosis, patients with celiac disease had an almost 4-fold higher risk of IBD, and patients with IBD had more than a 5-fold higher risk of celiac disease.
  Medscape Medical News, June 09, 2022